Xue-Rong Chen1, Jin-Wei Wang, Xiang Li, Hong Zhang, Zai-Yuan Ye. 1. Department of Oncology, First People's Hospital of Taizhou, No. 218 Hengjie Road, Huangyan District, Taizhou 318020, Zhejiang Province, China. cxr2999@yahoo.com.cn
Abstract
AIM: To investigate the relation between gastric cancer and microsatellite instability (MSI), loss of heterozygosity (LOH) and promoter region methylation. METHODS: Fifty primary gastric carcinoma specimens were collected from patients with no family history of cancer. In addition, normal tissues were also collected from patients as controls. DNA was extracted by polymerase chain reaction for single-strand conformation polymorphism, bisulfite DNA sequencing, and methylation-specific band analysis. RESULTS: The positive rate for MSI and LOH in gastric carcinoma was 16% and 20%, respectively. According to the tumor, node and metastasis staging system, the LOH frequency was higher in gastric carcinoma at stages III and IV than in gastric carcinoma at stages I and II (P = 0.01), which was also significantly correlated with lymph node metastasis and clinico- pathological characteristics of gastric carcinoma. Methylation of bone morphogenetic protein 3 (BMP3) gene promoter was detected in 64.44% of gastric carcinoma tissue samples. However, no statistical significance was observed between promoter region methylation and carcinoma differentiation. Interestingly, the BMP3 gene methylation rate was 71.05% and 28.58%, respectively, in MSI positive and negative cases (P = 0.031), suggesting that BMP3 genetic instability and promoter methylation are initiated during gastric carcinogenesis. LOH was detected mostly in the late stages of gastric carcinoma, indicating that gastric carcinoma at late stages has a higher infiltration and a poorer prognosis. CONCLUSION: Promotor region methylation of the BMP3 gene may cause gastric carcinoma in Chinese people. 2010 Baishideng. All rights reserved.
AIM: To investigate the relation between gastric cancer and microsatellite instability (MSI), loss of heterozygosity (LOH) and promoter region methylation. METHODS: Fifty primary gastric carcinoma specimens were collected from patients with no family history of cancer. In addition, normal tissues were also collected from patients as controls. DNA was extracted by polymerase chain reaction for single-strand conformation polymorphism, bisulfite DNA sequencing, and methylation-specific band analysis. RESULTS: The positive rate for MSI and LOH in gastric carcinoma was 16% and 20%, respectively. According to the tumor, node and metastasis staging system, the LOH frequency was higher in gastric carcinoma at stages III and IV than in gastric carcinoma at stages I and II (P = 0.01), which was also significantly correlated with lymph node metastasis and clinico- pathological characteristics of gastric carcinoma. Methylation of bone morphogenetic protein 3 (BMP3) gene promoter was detected in 64.44% of gastric carcinoma tissue samples. However, no statistical significance was observed between promoter region methylation and carcinoma differentiation. Interestingly, the BMP3 gene methylation rate was 71.05% and 28.58%, respectively, in MSI positive and negative cases (P = 0.031), suggesting that BMP3 genetic instability and promoter methylation are initiated during gastric carcinogenesis. LOH was detected mostly in the late stages of gastric carcinoma, indicating that gastric carcinoma at late stages has a higher infiltration and a poorer prognosis. CONCLUSION: Promotor region methylation of the BMP3 gene may cause gastric carcinoma in Chinese people. 2010 Baishideng. All rights reserved.
Authors: L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton Journal: Science Date: 1993-05-07 Impact factor: 47.728
Authors: Michael G House; James G Herman; Ming Zhou Guo; Craig M Hooker; Richard D Schulick; John L Cameron; Ralph H Hruban; Anirban Maitra; Charles J Yeo Journal: Surgery Date: 2003-12 Impact factor: 3.982
Authors: M E Candusso; O Luinetti; L Villani; P Alberizzi; C Klersy; R Fiocca; G N Ranzani; E Solcia Journal: J Pathol Date: 2002-05 Impact factor: 7.996
Authors: John B Kisiel; Tracy C Yab; William R Taylor; Suresh T Chari; Gloria M Petersen; Douglas W Mahoney; David A Ahlquist Journal: Cancer Date: 2011-09-22 Impact factor: 6.860
Authors: Young Ock Kim; Il Ki Hong; Young Gyu Eun; Seong-Su Nah; Soojeong Lee; Su-Hak Heo; Hyung-Kee Kim; Ho-Yeon Song; Hak-Jae Kim Journal: Oncol Lett Date: 2012-10-10 Impact factor: 2.967
Authors: Gustavo A Barisone; Tin Ngo; Martin Tran; Daniel Cortes; Mehdi H Shahi; Tuong-Vi Nguyen; Daniel Perez-Lanza; Wanna Matayasuwan; Elva Díaz Journal: PLoS One Date: 2012-07-10 Impact factor: 3.240
Authors: John B Kisiel; Jia Li; Hongzhi Zou; Abdul M Oseini; Benjamin B Strauss; Kadra H Gulaid; Catherine D Moser; Ileana Aderca; David A Ahlquist; Lewis R Roberts; Abdirashid M Shire Journal: J Mol Biomark Diagn Date: 2013-08-03